We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service Provider Program
News

Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service Provider Program

Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service Provider Program
News

Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service Provider Program

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service Provider Program"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Roche NimbleGen has announced that Eurofins MWG Operon, an Ebersberg, Germany-based company, has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Titanium Optimized Sequence Capture coupled with sequencing services from 454 Life Sciences, a Roche Company.

Eurofins MWG Operon has passed a rigorous certification test plan to achieve precise experimental standards to officially become part of the Roche NimbleGen Certified Service Provider Program. Their certification marks the first genomic service provider to join the global Roche NimbleGen CSP Program in Europe. They will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture workflow optimized for 454 Titanium sequencing using 385K Arrays.

"The Sequence Capture technology of Roche NimbleGen is a perfect fit to our next-generation sequencing platform," said Bruno Poddevin, Ph.D., Head of Eurofins Genomic Services, “and contributes significant speed and an optimized workflow to support our position as a leading provider of state-of the art services to our customers.”

“Roche NimbleGen welcomes Eurofins MWG Operon as our first European certified service provider for our innovative Sequence Capture technology. We anticipate that our relationship with Eurofins MWG Operon will result in significant growth for the targeted resequencing market and will serve as a model CSP to further expand our service channels on a country, regional, and global level," said Dr. Gerd Maass, CEO of Roche NimbleGen, Inc.
Advertisement